Skip to content

PRODUCT PIPELINE

pipeline-bottle-icon
Azurity Pharmaceuticals is focused on bringing novel, high-value products to patients. We have established a robust and diversified product pipeline with numerous late-stage development assets across an expanding variety of dosage formulations.

Pipeline
Products

Therapy/ Product Pathway Early-Stage
Development
Late-Stage
Development
Under Review
Therapy/ Product Pathway Early-Stage Late-Stage Under Review
CARDIOVASCULAR
AZ-01 505(b)(2)
Chronic Stable Angina – AR36* 505(b)(1)
Acute Mountain Sickness – AR36* 505(b)(1)

CENTRAL NERVOUS SYSTEM
AZ-02 505(b)(2)
AZ-03 505(b)(2)
AZ-04 505(b)(2)
AZ-06 505(b)(2)
AZ-07 505(b)(2)
AZ-08 505(b)(2)
GASTROINTESTINAL
RM-02 505(b)(2)
RM-03 505(b)(2)
RM-06 505(b)(2)
ENDOCRINOLOGY
AR-38 505(b)(2)
*Collaboration with development partner. Commercialization via Azurity.

We are actively pursuing additional opportunities to grow our pipeline through a combination of organic and inorganic opportunities.

Azurity is always interested in collaborating with development partners or manufacturers to bring new and innovative products to market. If you are interested in partnering with Azurity Pharmaceuticals, please contact business.development@azurity.com.